Effect of letrozole and dexamethasone combination therapy compared to letrozole alone for ovulation induction in infertile women with polycystic ovary syndrome: a randomized controlled trial

M. Ariful Islam; Humaira Alam; Fawzia Hossain; Sumyara Khatun; Amitun Nessa; Rebeka Sultana; Mostafa M. Al Tarique; Jesmine Banu

doi:10.18203/2320-1770.ijrcog20253069

Authors

M. Ariful Islam Department of Reproductive Endocrinology and Infertility, Directorate General of Health Services (DGHS), Mohakhali, Dhaka, Bangladesh
Humaira Alam Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh
Fawzia Hossain Department of Gynaecological Oncology, Bangladesh Medical University, Dhaka, Bangladesh
Sumyara Khatun Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh
Amitun Nessa Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh
Rebeka Sultana Department of Reproductive Endocrinology and Infertility, Directorate General of Health Services (DGHS), Mohakhali, Dhaka, Bangladesh
Mostafa M. Al Tarique Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh
Jesmine Banu Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20253069

Keywords:

PCOS, Letrozole, Dexamethasone, Ovulation induction

Abstract

Background: Polycystic ovary syndrome (PCOS), a common cause of anovulatory infertility, affects 5–10% of reproductive-age women. Hyperandrogenemia disrupts follicular development. Dexamethasone may enhance folliculogenesis. This study compared letrozole plus dexamethasone versus letrozole alone for ovulation induction in infertile PCOS women.

Methods: This randomized controlled trial was conducted at the Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, from September 2023 to August 2024. 72 infertile PCOS women (18-35 years) were allocated into 2 groups. Group A (36 patients) received letrozole 7.5 mg/day for 5 days with dexamethasone 0.5 mg twice daily for 10 days from cycle day 2. Group B (36 patients) received letrozole 7.5 mg/day for 5 days from cycle day 2 for 3 cycles. TVS folliculometry assessed ovarian response on day 12-14. HCG injection was given for mature follicles. Ovulation was confirmed by mid-luteal progesterone and pregnancy by serum B-HCG.

Results: Group A showed more mature follicles than group B, notably in the 3rd cycle (76.7% vs 51.6%, p<0.05). Endometrial thickness was greater in Group A in both 2nd (7.7±1.4 vs 6.6±0.9 mm, p<0.05) and 3rd cycles (7.9±1.4 vs 6.7±1.0 mm, p<0.05). Ovulation rates were higher in Group A, reaching significance in the 3rd cycle (76.7% vs 51.6%, p<0.05). Cumulative pregnancy rates favored Group A (30.6% vs 19.4%), though not significantly.

Conclusions: Letrozole plus dexamethasone is more effective than letrozole alone in enhancing follicular development, endometrial thickness, ovulation, and pregnancy outcomes in women with PCOS.

Metrics

Metrics Loading ...

References

Khurana A, Swamy MV, Mitra S, Srinivas S, Nagaraja N. Prevalence of polycystic ovarian syndrome, phenotypes and their ovulation response to sequential letrozole dose escalation among infertile women at a tertiary care centre in southern India. J Hum Reprod Sci. 2022;15(1):42-50. DOI: https://doi.org/10.4103/jhrs.jhrs_141_21

Dumont A, Robin G, Catteau-Jonard S, Dewailly D. Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol. 2015;13:1-0. DOI: https://doi.org/10.1186/s12958-015-0134-9

Hajishafiha M, Dehghan M, Kiarang N, Sadegh-Asadi N, Shayegh SN, Ghasemi-Rad M. Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome. Drug Des Devel Ther. 2013;7:1427-31. DOI: https://doi.org/10.2147/DDDT.S50972

Wang R, Mol BW. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria. Hum Reprod. 2017;32(2):261-4. DOI: https://doi.org/10.1093/humrep/dew287

Priya M, Nanthini A, Bini K. Polycystic ovary syndrome: An updated review. Int J Health Allied Sci. 2019;8(4):229. DOI: https://doi.org/10.4103/ijhas.IJHAS_9_19

Rosenfield RL. Menstrual disorders and hyperandrogenism in adolescence. In Pediatric Endocrinology: A Practical Clinical Guide. Totowa, NJ: Humana Press. 2003: 451-478. DOI: https://doi.org/10.1385/1-59259-336-4:451

Taylor HS, Pal L, Sell E. Speroff's clinical gynecologic endocrinology and infertility. Lippincott Williams & Wilkins; 2019.

Begum MR, Ehsan M, Begum MS, Khan F, Baby HA, Siddiqui M, Quadir E. Beneficial effects of addition of glucocorticoid during induction of ovulation by letrozole in polycystic ovarian syndrome. J South Asian Federation Obstet Gynecol. 2012;4:85-9. DOI: https://doi.org/10.5005/jp-journals-10006-1180

Hillier SG, Tetsuka M. 3 Role of androgens in follicle maturation and atresia. Bailliere's Clin Obstet Gynaecol. 1997;11(2):249-60. DOI: https://doi.org/10.1016/S0950-3552(97)80036-3

Steinberger E, Smith KD, Tcholakian RK, Rodriguez-Rigau LJ. Testosterone levels in female partners of infertile couples: relationship between androgen levels in the woman, the male factor, and the incidence of pregnancy. Am J Obstet Gynecol. 1979;133(2):133-8. DOI: https://doi.org/10.1016/0002-9378(79)90463-0

Conant RJ, Dubaut JP, Hansen KR, Craig L, Burks H, Quaas AM. Letrozole “stair-step” protocol in patients with polycystic ovary syndrome. Fertil Steril. 2017;107(3): e17. DOI: https://doi.org/10.1016/j.fertnstert.2017.02.031

Thomas S, Woo I, Ho J, Jones T, Paulson R, Chung K, Bendikson K. Ovulation rates in a stair-step protocol with Letrozole vs clomiphene citrate in patients with polycystic ovarian syndrome. Contracept Reprod Med. 2019;4:1-6. DOI: https://doi.org/10.1186/s40834-019-0102-4

Garg N, Vanitha VG. A Comparative Study of Letrozole Vs Clomiphene Citrate as First Line for Anovulatory Infertility–An Institutional Experience. Asian Res J Gynaecol Obstetr. 2019;2(1):1-8.

Begum MR, Ferdous J, Begum A, Quadir E. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril. 2009;92(3):853-7. DOI: https://doi.org/10.1016/j.fertnstert.2007.08.044

Daly DC, Walters CA, Soto-Albors CE, Tohan N, Riddick DH. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril. 1984;41(6):844-8. DOI: https://doi.org/10.1016/S0015-0282(16)47896-9

Thabet M, Abdelrazik MM. Adding Prednisolone During Ovulation Induction with Clomiphene Citrate in Lean Women with Clomiphene Citrate Resistant Polycystic Ovarian Syndrome. Egyptian J Fertil Steril. 2019;23(1):16-22. DOI: https://doi.org/10.21608/egyfs.2019.105398

Farzaneh F, Afshar F. Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: An RCT. Int J Reprod BioMed. 2020;18(4):307. DOI: https://doi.org/10.18502/ijrm.v13i4.6893

Ashrafi M, Zafarani F, Tehrani ES, Owj M, Baghestani AR, Amirchaghmaghi E. Effect of Dexamethasone on ovarian response in infertile women aged over 35 years undergoing IVF/ICSI program. J Reprod Infertil. 2004;5(4).

Al-Shaikh SF, Fadhil I. Prednisolone with clomiphene citrate in ovulation induction in clomiphene citrateresistant polycystic ovary syndrome. Med J Babylon. 2010;7:571-8.

E Shaheen AH, El-Naggar AM, F Al-Halby AE, Shabana AA. Letrozole with dexamethasone versus clomiphene citrate with dexamethasone for induction of ovulation in polycystic ovary. Menoufia Med J. 2018;31(1):38-45.

Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685-97. DOI: https://doi.org/10.1016/S0140-6736(07)61345-2

Vanky E, Salvesen KÅ, Carlsen SM. Six‐month treatment with low‐dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin. Hum Reprod. 2004;19(3):529-33. DOI: https://doi.org/10.1093/humrep/deh103

Keay SD, Lenton EA, Cooke ID, Hull MG, Jenkins JM. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum Reprod. 2001;16(9):1861-5. DOI: https://doi.org/10.1093/humrep/16.9.1861

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-18. DOI: https://doi.org/10.1093/humrep/dey256

Casper RF. Aromatase inhibitors in ovarian stimulation. J Steroid Biochem Molecular Biol. 2007;106(1-5):71-5. DOI: https://doi.org/10.1016/j.jsbmb.2007.05.025

Esmaeilzadeh S, Amiri MG, Basirat Z, Shirazi M. Does adding dexamethasone to clomiphene citrate improve ovulation in PCOS patients? A triple-blind randomized clinical trial study. Int J Fertil Steril. 2011;5(1):9.

Zhu X, Fu Y. Extending letrozole treatment duration is effective in inducing ovulation in women with polycystic ovary syndrome and letrozole resistance. Fertil Steril. 2023;119(1):107-13. DOI: https://doi.org/10.1016/j.fertnstert.2022.09.018

Dai X, Li J, Fu T, Long X, Li X, Weng R, Liu Y, Zhang L. Ovulation induction using sequential letrozole/gonadotrophin in infertile women with PCOS: a randomized controlled trial. Reproductive BioMedicine Online. 2023;46(2):352-61. DOI: https://doi.org/10.1016/j.rbmo.2022.08.002

Basirat Z, Zeinalzadeh M, Mahouti T, Golsorkhtabaramiri M. Impact of dexamethasone on pregnancy outcome in PCOs women candidate for IVF/ICSI, a single-blind randomized clinical trial study. Middle East Fertility Society J. 2016;21(3):184-8. DOI: https://doi.org/10.1016/j.mefs.2016.01.001

Neblett MF, Baumgarten SC, Babayev SN, Shenoy CC. Ovulation induction with letrozole and dexamethasone in infertile patients with letrozole-resistant polycystic ovary syndrome. J Assisted Reprod Genet. 2023;40(6):1461-6. DOI: https://doi.org/10.1007/s10815-023-02817-9